The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

Date
2010
Author
DEPRESSEUX, G.
Guel, Ahmet
CATTANEO, R.
FONT, J.
COSYNS, J-P
CERVERA, R.
HOUSSIAU, F. A.
VASCONCELOS, C.
D'CRUZ, D.
BLOCKMANS, D.
SEBASTIANI, G. D.
DE RAMON GARRIDO, E.
DANIELI, M. G.
Abramovicz, D.
CAULI, A.
Direskeneli, H.
GALEAZZI, M.
LEVY, Y.
PETERA, P.
POPOVIC, R.
PETROVIC, R.
SINICO, R. A.
Metadata
Show full item record
Abstract
Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) cyclophosphamide (CY) followed by azathioprine (AZA) as treatment for proliferative lupus nephritis.
URI
http://hdl.handle.net/20.500.12627/10732
https://doi.org/10.1136/ard.2008.102533
Collections